Key Strategies for Successful Orphan Drug Launch in Europe, Upcoming Webinar Hosted by Xtalks
Tuesday, March 18, 2025
In this free webinar, learn about the importance of early patient engagement in shaping access strategies. Attendees will gain insights into key market access, pricing and reimbursement challenges in Europe. The featured speakers will share effective approaches to navigating regulatory and commercialisation hurdles. Attendees will learn how patient advocacy partnerships can enhance launch success.
TORONTO, March 10, 2025 /PRNewswire-PRWeb/ -- Bringing an orphan drug to market in Europe can be complex. Stricter regulations, evolving pricing pressures, and the growing influence of patient advocacy present significant challenges that can lead to delays and barriers to expanding into these key markets. A well-defined access strategy is essential to navigate the EU landscape effectively.
Securing reimbursement and market access now requires earlier engagement with stakeholders, a patient-centric approach, and a deep understanding of evolving pricing policies. Without the right strategy, companies risk delays, restricted access or commercial failure.
This webinar will equip you with expert insights on patient engagement, pricing and reimbursement and regulatory navigation.
The expert speakers reveal the essential strategies for overcoming these challenges and securing a successful launch:
-- Highlighting why early patient engagement is critical not just for
regulatory approval but for building trust and ensuring long-term
adoption
-- Latest trends in European market access, pricing and reimbursement,
providing strategies to stay ahead in a rapidly evolving landscape
-- Providing a patient advocacy perspective, illustrating how industry
collaboration can unlock new market access opportunities
If involved in orphan drug development, the attendees will gain practical, expert-backed strategies to avoid costly pitfalls, accelerate access and maximize launch success in 2025.
Register for this webinar today to optimize pricing and reimbursement strategies and leverage patient advocacy for a successful market launch of orphan drugs.
Join Dr. Raymond A. Huml, Vice President of Rare Strategy, Sciensus; Andrew Cummins, Vice President of Business Development, Sciensus; and Kirsty Hoyle, CEO, Metabolic Support UK, for the live webinar on Friday, March 28, 2025, at 1pm EDT (5pm GMT).
For more information, or to register for this event, visit Key Strategies for Successful Orphan Drug Launch in Europe.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com
View original content to download multimedia:https://www.prweb.com/releases/key-strategies-for-successful-orphan-drug-launch-in-europe-upcoming-webinar-hosted-by-xtalks-302396660.html
SOURCE Xtalks
|
|
|
|
|
 |
VIAVI Highlights Test Solutions for AI Infrastructure Development, Manufacturing and Deployment at OFC 2025 | Mar 28, 2025
|
|
Oracle Helps Customers Boost Employee Engagement with Strategic Communications and Internal Events | Mar 28, 2025
|
|
ThreatQuotient positioned as a Leader in the SPARK Matrix(TM): Digital Threat Intelligence Management, 2025 by QKS Group | Mar 28, 2025
|
|
Orium Launches Composable Accelerator for Shopify | Mar 28, 2025
|
|
Madame Rachida Dati, French Minister of Culture, has granted official recognition to thierry Ehrmann's Abode of Chaos as a 'total work of art', the global headquarters of Artprice by Artmarket. | Mar 28, 2025
|
|
Datacenter Dynamics Makes History with LoneStar - Becoming the World's First Magazine to Reach the Moon | Mar 28, 2025
|
|
Nosto reports 323% growth of Personalized Search after 2024 Gartner MQ inclusion | Mar 28, 2025
|
|
Western Union forms strategic partnership with HCLTech to transition to an AI led platform operating model | Mar 28, 2025
|
|
Wealthbox Expands to Canada with In-Country Data Hosting | Mar 28, 2025
|
|
Direct Digital Holdings Launches "Practical Generative AI Use Cases & Tools for DMOs" to Help Break New Ground in Destination Marketing With AI | Mar 28, 2025
|
|
|
